Huang Hui-Fen, Liu Qi-Bing, Xu Yong-Feng, Zhao Gui-Xian, Liu Hai-Peng, Yu Hao, Wu Zhi-Ying
Department of Medical Genetics and Center for Rare Diseases, Second Affiliated Hospital, Zhejiang University School of Medicine and Zhejiang Key Laboratory of Rare Diseases for Precision Medicine and Clinical Translation, Hangzhou, China.
Department of Neurology, Lishui Hospital, Zhejiang University School of Medicine, Lishui, China.
Front Neurol. 2025 Jul 4;16:1552149. doi: 10.3389/fneur.2025.1552149. eCollection 2025.
This study aims to investigate the association of Fc receptor-like 3 () gene variants with multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) in a Chinese population cohort.
In Stage 1, 154 MS patients, 109 NMOSD patients, and 301 normal controls were recruited, Sequenom MassARRAY technology was used for genotyping single nucleotide polymorphisms (SNPs). Stage 2 involved an independent cohort of 95 MS patients, 139 NMOSD patients, and 226 normal controls. Two SNPs (rs7528684 and rs11264799) were determined using allele-specific polymerase chain reaction (PCR) with specific primers.
Allele C of rs7528684 emerged as a protective factor for MS. Allele A of rs11264799 exhibited no significant effect on MS or NMOSD. A notable disparity in rs7528684 genotype distribution was observed between oligoclonal band (OCB)-positive and OCB-negative MS patients. Allele C of rs7528684 exhibited an association with OCB-positive MS patients.
The findings suggest that the variant (rs7528684) is associated with MS rather than NMOSD. might significantly contribute to OCB synthesis, while the underlying mechanisms warrant further elucidation.
本研究旨在调查在中国人群队列中,Fc受体样3(FcRL3)基因变异与多发性硬化症(MS)和视神经脊髓炎谱系障碍(NMOSD)之间的关联。
在第一阶段,招募了154例MS患者、109例NMOSD患者和301名正常对照,采用Sequenom MassARRAY技术对单核苷酸多态性(SNP)进行基因分型。第二阶段纳入了一个独立队列,包括95例MS患者、139例NMOSD患者和226名正常对照。使用等位基因特异性聚合酶链反应(PCR)和特异性引物测定两个SNP(rs7528684和rs11264799)。
rs7528684的等位基因C是MS的保护因素。rs11264799的等位基因A对MS或NMOSD无显著影响。在寡克隆带(OCB)阳性和OCB阴性MS患者之间,观察到rs7528684基因型分布存在显著差异。rs7528684的等位基因C与OCB阳性MS患者相关。
研究结果表明,FcRL3变异(rs7528684)与MS相关,而非与NMOSD相关。FcRL3可能对OCB合成有显著贡献,但其潜在机制有待进一步阐明。